Book Value per Share: BioVie Pharma (BIVI)

Graphic logo of BioVie (BIVI)

The estimated book value per share helps assess the market launch plan for cirrhosis and dementia therapies for BioVie Inc. (BIVI). The company is currently seeking a strategic partner to rescue the business following failed tests. Patents in the field of chronic pathologies create a foundation for future revenues, while the 1.36 metric confirms the current level. The indicator's dynamics allow for the filtering of market noise to reveal the actual speed of asset accumulation.

BioVie Pharma (BIVI): Share Book Value from 07/04/2022 to 10/27/2026

BioVie Inc - analytical breakdowns and key metrics (BIVI)

- price and consensus price forecast:
Stock Quotes BioVie Pharma|BIVI - Price Target Chart
- market capitalization data:
Market Capitalization BioVie Inc.|BIVI - Company Buyout Price
- book capitalization data:
Net Assets per Single Share BioVie|BIVI - Net Asset Value|Market Capitalization to Book Value Ratio biovieinc.com|BIVI - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital BioVie Inc.|BIVI - Long-Term Debt to Capital|Short-Term Debt to Equity BioVie Pharma|BIVI - Aggregate Debt Obligations|Debt to Book Capitalization Ratio BioVie Inc.
Fundamental company valuation:biovieinc.com - BIVI
Manufactured products of BioVie Pharma

Investors assess the fundamental reliability of a business through the difference between total assets and liabilities allocated per share. By analyzing the current book value per share, one can verify the actual equity of BioVie Inc. (BIVI), where growth in this metric confirms the company's financial stability while developing drugs for neurodegenerative disorders and conducting costly clinical trials.

Competitors of BioVie Inc. (BIVI)

ARWR - Accounting Value per Share|MIRM - Net Assets per Single Share|Dynavax Pharma - Book Value per Share|ABUS (arbutusbio.com) - Net Assets per Share|Net Assets per Single Share Inventiva IVA|Share Book Value Gyre Therapeutics Inc|Assembly Biosciences Inc (ASMB) - Book Value per Share|Accounting Value of a Share galectintherapeutics.com (GALT)|Book Value per Share GNFT (GENFIT)|DURECT Corp - Book Value per Share|Net Assets per Single Share Aligos (ALGS)|GLMD: Accounting Value of a Share|NDRA (ENDRA) - Net Assets per Single Share|Hepion Pharmaceuticals, Inc. (HEPA) - Accounting Value per Share